About the Organization.
BM is a fast-growing preclinical drug research and development service provider, founded by senior CRO veterans with decades of management and leadership experience. Serving global pharmaceutical and biotechnology clients, BM is headquartered in the heart of Zhangjiang Pharma Valley, Shanghai, with more than 6,000 sq ft of state-of-the-art R&D space. Facilities include AAALAC-compliant SPF animal facilities and biosafety level-2 laboratories.
BM’s one-stop platform offers comprehensive preclinical solutions, spanning target validation, protein and antibody production, in vitro assays, cell analytics, in vivo pharmacology/PK/PD, and exploratory toxicology. Their 100+ scientist team leverages proprietary platforms such as the MetaCHO antibody expression system and a tumor cell bank with nearly 1,000 unique cell lines, enabling leading-edge research services.
















